Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
40.82
-0.53 (-1.28%)
At close: Nov 18, 2025, 4:00 PM EST
40.81
-0.02 (-0.04%)
After-hours: Nov 18, 2025, 4:07 PM EST
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $1.75 billion as of November 18, 2025. Its market cap has increased by 113.82% in one year.
Market Cap
1.75B
Enterprise Value
1.20B
1-Year Change
113.82%
Ranking
Category
Stock Price
$40.82
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $1.75B, an increase of 973.25%. That is a compound annual growth rate of 196.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 1.77B | 174.78% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |